Baidu
map

小女孩买“PDE5抑制剂”被药师质疑 社会对这种药的误解有多深

2019-09-06 崔馨竹(整理) 健康界

看破:女孩买“伟哥”被质疑 这种药何时能被正名据媒体今日报道,河南许昌8岁女孩小雅,跑到药店买“伟哥”引起现场群众的好奇,有药剂师现场质疑“家教不严”,而小雅母亲只得流泪解释真相。这种药,小女孩已经吃了5年,她3岁就患上肺动脉高压,从那时开始就靠这药续命,而且每天都吃。研发伟哥是为了治疗心血管疾病,改善男性性功能只是意外发现。由于价格相对便宜,此类药物成为我国肺动脉高压治疗的一线药物。据悉,每日靠

看破:女孩买“伟哥”被质疑 这种药何时能被正名

据媒体今日报道,河南许昌8岁女孩小雅,跑到药店买“伟哥”引起现场群众的好奇,有药剂师现场质疑“家教不严”,而小雅母亲只得流泪解释真相。这种药,小女孩已经吃了5年,她3岁就患上肺动脉高压,从那时开始就靠这药续命,而且每天都吃。

研发伟哥是为了治疗心血管疾病,改善男性性功能只是意外发现。由于价格相对便宜,此类药物成为我国肺动脉高压治疗的一线药物。据悉,每日靠“伟哥”续命的肺动脉高压患者在我国已超500万。

点评:在很多国家它都注册了肺动脉高压的适应证,但在中国它的适应证依然只有“男性勃起功能障碍”(ED)。靠“伟哥”续命的患者数量如此庞大,药店药剂师不了解它的功效,却去质疑女孩“家教不严”,真实岂有此理!另外,“伟哥”的剂量标准针对ED,很多肺动脉高压患者需要把一片药掰成4-5份吃。面对如此庞大的需求,其在我国的适应证是不是也该尽快调整了?

看破:医生带病完成手术 心疼之外更应避免

这两天,一张医生身着手术服缩成一团、席地而坐的照片在河南省内医护圈刷屏。

照片里的医生是心脏大血管外科副主任医师朱贵军,当天朱贵军连续做了两场、总计时长近16个小时的急诊手术。第二场手术接近尾声时,病人逐步恢复生命体征,朱贵军却突发肾结石,但他强忍着绞痛完成手术最后的步骤,直至病人安全返回监护室后,他疼得坐地不起,缩成一团……

点评:记得医师节那天,有个律师朋友发了这样一条朋友圈:少谈崇高,多保护医生作为普通人的权益。不要用“崇高”来绑架医生,少宣传几分钱治好病人。回到这条新闻,祝朱主任早日恢复健康!

看衰:医院领导“抄作业连名字一起抄” 这是有多敷衍

湖北宜昌市纪委监委网站通报称,近期全市各级纪检监察机关严肃查处了一批形式主义、官僚主义突出问题,并公布典型案例。

通报称,宜都市中医医院党总支书记刘斌文风不实、照搬照抄问题。2018年5月,宜都市中医医院在准备八届宜都市委第三轮巡察资料过程中,刘斌上交的“四讲四有”心得体会照搬照抄网上内容,出现“开封创卫”、“四个开封”等不实内容。刘斌被宜都市纪委给予通报问责处理。

点评:上学时抄作业,本质是“想办法做成自己不想做又不得不做的事”,这位院领导的做法大概也是如此。不知道他在别的工作上会不会也有类似情况呢?还请记得,抄作业别把名字也抄上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2020-08-15 jklm09
  2. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2019-10-04 saikp
  4. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2019-09-08 snf701212
  5. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1852119, encodeId=2e3e1852119e9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54918, encryptionId=f0a254918f0, topicName=抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Sat Aug 15 23:26:00 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984884, encodeId=9dac1984884fe, content=<a href='/topic/show?id=b9e21394eba' target=_blank style='color:#2F92EE;'>#PDE5抑制剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13947, encryptionId=b9e21394eba, topicName=PDE5抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jan 31 04:26:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735139, encodeId=dbe61e3513998, content=<a href='/topic/show?id=9aa5923e176' target=_blank style='color:#2F92EE;'>#质疑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92371, encryptionId=9aa5923e176, topicName=质疑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3033872914, createdName=saikp, createdTime=Fri Oct 04 16:26:00 CST 2019, time=2019-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568452, encodeId=b440156845288, content=<a href='/topic/show?id=3b5c91852e0' target=_blank style='color:#2F92EE;'>#误解#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91852, encryptionId=3b5c91852e0, topicName=误解)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eeb15379220, createdName=snf701212, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616979, encodeId=6cd316169e949, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Sun Sep 08 13:26:00 CST 2019, time=2019-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372373, encodeId=506f3e237352, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Sep 06 22:37:13 CST 2019, time=2019-09-06, status=1, ipAttribution=)]
    2019-09-06 一个字-牛

    学习了谢谢分享

    0

相关资讯

WHO:世界抗生素耐药性实况报道、认知误解及战略目标

重要事实 如今,抗生素耐药性是对全球卫生的最大威胁。它会影响每个人,无论其年龄和国籍。 抗生素耐药性是自然发生的,但在人类和动物间误用抗生素会加速发生耐药的过程。 越来越多的感染(比如肺炎、结核和淋病)变得更难治疗,原因在于用于治疗感染的抗生素不如原来有效。 抗生素耐药性会导致更长的住院时间,更高的医疗费用和更多死亡。 概况 抗生素是

艾滋病疫苗真的已经来了?这是一场媒体的误导和公众的误读

人类等待第一款艾滋病疫苗诞生的心情是迫切的。8月9日,一条“强生宣布HIV疫苗临床试验结果:志愿者100%产生抗体”的微博,半天内就转发过2万。有人评论:“HIV灭绝了,下一个是什么”、“今年的诺奖有着落了?”但记者询问两位研究艾滋病的学者、查阅相关资料后了解到,这是一次媒体的误导和公众的误读。美国强生公司的这一阶段性成果值得关注,但在获得更多实验数据前,做出“艾滋病疫苗真的要来了”的判断还为

医媒对立何时了?记者对医者的误解着实有点深……

作为医者,我们苦苦追求的,并非出将入相的辉煌,而是一种救死扶伤的经历;我们痴痴寻找的,并非经天纬地的成就,而是在每一个病例中上下求索抽丝剥茧的无悔。

我接力!请尊重医务人员!尊重生命!

导语:这些瞬间有没有让你感动?这些瞬间有没有让你感动?医生一天完成18台手术,穿着手术服,蜷缩在地上睡着了;医生强忍痉挛剧痛,坚持完成手术最关键步骤,走下手术台后,直接倒地;医生值夜班时腰椎间盘突出复发,剧痛,又不忍心深夜联系同事来替班,只能趴在凳子上写护理记录单;在大学纷飞的日子,依旧是一次次的出诊,不畏风寒........他们与时间赛跑的斗士,却常常被埋怨误解;他们真的很苦很累,却总说“这没什

这些医学专业,真的经常被误解!

生活当中很多人会通过专业名字来判断一个专业未来所从事的行业,也经常会遇到一些令人哭笑不得的专业误会。尤其是对医学领域许多专业,都常被人所误解。康复治疗=盲人推拿的?专业介绍康复治疗学专业是一个融合康复、医疗、预防、保健为一体的专业。是使病、伤、残者康复的重要手段,常与药物治疗、手术疗法等临床治疗综合进行。通常会借助按摩、针灸等方式改善人体肌力、肌耐力,或者通过患者锻炼来治疗疾病。就业方向主要到综

Baidu
map
Baidu
map
Baidu
map